Skip to main content
. 2018 Jun 21;2018(6):CD007105. doi: 10.1002/14651858.CD007105.pub4

NCT00418457.

Trial name or title Regional anaesthesia and breast cancer recurrence: prospective, randomized, double‐blinded, multicenter clinical trial to compare postoperative analgesia and cancer outcome after combined paravertebral versus thoracic epidural versus general anaesthesia for breast cancer surgery
Methods Prevention, randomized, open‐label, active‐control, parallel‐assignment, efficacy study
Participants Ages eligible for study: 18‐85 years
Genders eligible for study: women only
Estimated enrolment: 1600
Women undergoing mastectomies or isolated lumpectomy with axillary node dissection
Interventions Combined paravertebral vs thoracic epidural vs general anaesthesia
Outcomes Primary outcome is cancer recurrence with a follow‐up of 5 years. Secondary outcomes include chronic pain, among others, with a follow‐up of 6 and 12 months
Starting date January 2007
Contact information Nancy Graham, RN       
Tel: +1216‐445‐7530    
e‐mail: grahamn@ccf.org
Notes